CES: Consumer medical device is capable of detecting serious conditions
Withings has kicked off CES with a bang by launching the BeamO – a four in one device designed to take medical-grade readings at home.
The BeamO packs in an ECG, oximeter, stethoscope, and thermometer – to create a series of medical readings.
The device itself is a small handheld unit, around the same size as a smartphone. It looks like a remote for your aircon unit, and a super-charged version of the existing Withings Thermometer.
It will track body temperature, heart rate, ECG, blood oxygen levels and listen out for respiratory sounds.
That means it can detect atrial fibrillation, heart murmurs, lung wheezing and desaturation, which from a detection perspective, makes it one of the most advanced consumer health devices we’ve seen to date.
The digital stethoscope enables you to take recordings of heart and lung sounds, which can be shared with your doctor, which can enable them to diagnose conditions such as bronchitis, COPD or asthma.
As well as detection, it will also offer medication reminders and tracking and the ability to log symptoms.
It also boasts 8 month of battery life, so it should be ready when you need it.
There’s no word on pricing yet, and the BeamO isn’t cleared by medical regulators, which will be essential given the detection element of the feature set.
Last CES, Withings unveiled the U-Scan, its urine examination system. While it has unveiled consumer smartwatches in 2023, CES seems to be the place to talk about the bleeding edge of its consumer health plans.
We’ll be going to see the BeamO in action this week, so stay tuned for our full hands-on.
